Specificity, Diversity, and Regulation in TGF-beta Superfamily Signaling
Overview
Authors
Affiliations
Transforming growth factor-beta (TGF-beta) superfamily members are multifunctional cell-cell signaling proteins that play pivotal roles in tissue homeostasis and development of multicellular animals. They mediate their pleiotropic effects from membrane to nucleus through distinct combinations of type I and type II serine/threonine kinase receptors and their downstream effectors, known as Smad proteins. Certain Smads, termed receptor-regulated Smads, become phosphorylated by activated type I receptors and form heteromeric complexes with a common-partner Smad4, which translocates into the nucleus to control gene transcription. In addition to these signal transducing Smads, inhibitory Smads have been identified that inhibit the activation of receptor-regulated Smads. In contrast to the still growing TGF-beta superfamily (with approximately 30 members in mammals), relatively few type I and type II receptors as well as Smads have been identified. We will focus on recent insights into the molecular mechanisms by which signaling specificity between different TGF-beta superfamily members is achieved and regulated, and how a single family member can elicit a broad scala of biological responses.-Piek, E., Heldin, C.-H., ten Dijke, P. Specificity, diversity, and regulation in TGF-beta superfamily signaling.
Oh S, Lee S, Jang J, Son K, Byun K Curr Issues Mol Biol. 2024; 46(12):14351-14365.
PMID: 39727988 PMC: 11674791. DOI: 10.3390/cimb46120860.
Inflammation accelerating intestinal fibrosis: from mechanism to clinic.
Xin S, Liu X, He C, Gao H, Wang B, Hua R Eur J Med Res. 2024; 29(1):335.
PMID: 38890719 PMC: 11184829. DOI: 10.1186/s40001-024-01932-2.
Danielpour D Pharmaceuticals (Basel). 2024; 17(4).
PMID: 38675493 PMC: 11054419. DOI: 10.3390/ph17040533.
Tanveer M, Rashid H, Tasduq S Heliyon. 2023; 9(3):e13580.
PMID: 36895391 PMC: 9988502. DOI: 10.1016/j.heliyon.2023.e13580.
Smad7 as a positive regulator of intestinal inflammatory diseases.
Monteleone G, Laudisi F, Stolfi C Curr Res Immunol. 2023; 4:100055.
PMID: 36714553 PMC: 9881044. DOI: 10.1016/j.crimmu.2023.100055.